{"id": "1335982512623951884", "creation": 1607358027.0, "user_id": "65673617", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 8, "reply_count": 3, "like_count": 56, "quote_count": 1}}, "text": "Now @BharatBiotech seeks emergency use authorisation for its #COVID19 #vaccine #Covaxin\n\nAfter @pfizer and @SerumInstIndia, bharat biotech becomes 3rd company in India to write to DGCI", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#COVAXIN"]}